Researchers at Stanford University have utilized their EVO 2 AI model to design novel bacteriophages capable of targeting and killing Escherichia coli. The AI generated thousands of potential phage genomes, from which 16 were selected for laboratory synthesis and testing. These synthesized phages demonstrated significant efficacy against E. coli, even in strains resistant to existing treatments, highlighting AI's potential in combating antimicrobial resistance. AI
IMPACT Demonstrates AI's capability in designing novel biological agents, potentially accelerating drug discovery and combating antimicrobial resistance.
RANK_REASON Research paper detailing the use of an AI model to design novel biological agents.
Read on Mastodon — fosstodon.org →
- bacteriophage
- Brian L Hie
- Escherichia coli
- EVO 2
- Phi X 174
- Samuel T. King
- Stanford Data Science
- Stanford University
- Dieter Schwarz Foundation
AI-generated summary · Google Gemini · from 2 sources. How we write summaries →